ODDITY Tech Aktie News

Oddity combines high growth, profitability, and a data-driven advantage, differentiating it from traditional beauty brands and creating a compelling investment case. ODD leverages machine learning and direct-to-consumer models, fueling rapid revenue growth, high margins, and successful brand launches like IL MAKIAGE, SpoiledChild, and METHODIQ. After a 50% pullback, ODD trades at an attractive ...

Oddity's sales and profits are growing at an impressive clip. Management sees further gain ahead.

Oddity Tech Ltd. ( ODD ) Q3 2025 Earnings Call November 20, 2025 8:30 AM EST Company Participants Maria Lycouris Oran Holtzman - Co-Founder, CEO & Director Lindsay Mann - Global Chief Financial Officer Conference Call Participants Dara Mohsenian - Morgan Stanley, Research Division Anna Lizzul - BofA Securities, Research Division Youssef Squali - Truist Securities, Inc., Research Division Andrew...

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the third quarter ended September 30, 2025.

This quarter, we re-established a position in Arista Networks, a leading provider of high-performance networking solutions for data centers, cloud providers, and enterprises. We initiated a starter position in Synopsys after shares sold off following the company's third quarter earnings report and our in-person meeting with management. We exited our CyberArk Software Ltd. position after its acq...

Oddity, the maker of Il Makiage and Spoiled Child, launched its third brand Methodiq, a telehealth platform for medical skincare. Methodiq will offer 28 new products, including creams, supplements and cosmetics, that address acne, hyperpigmentation and eczema and range in price from about $29 to around $59.

NEW YORK--(BUSINESS WIRE)--ODDITY Tech Ltd. (NASDAQ: ODD) today announced the launch of METHODIQ, a medical telehealth platform delivering customized, high-efficacy treatments powered by online diagnosis – without needing to go to a doctor's office or get lost in a drug store. METHODIQ reimagines medical care with science, world-class treatments and AI analysis to deliver the highest standards ...

Baron International Growth Fund gained 6.04% during the quarter, slightly underperforming its benchmark, the MSCI ACWI ex USA Index. Lynas Rare Earths' shares nearly doubled during the quarter as geopolitical and trade tensions underscored the strategic importance of supply sources outside China. Constellation Software, a holding company that owns and operates a large portfolio of vertical-mark...